| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Zebrafish | 24 | 2025 | 339 | 2.330 |
Why?
|
| Zebrafish Proteins | 11 | 2025 | 159 | 2.240 |
Why?
|
| Insulin-Secreting Cells | 15 | 2025 | 440 | 2.090 |
Why?
|
| Pancreas | 7 | 2025 | 258 | 1.670 |
Why?
|
| Arachidonate 12-Lipoxygenase | 5 | 2025 | 26 | 1.310 |
Why?
|
| Regeneration | 6 | 2016 | 159 | 0.970 |
Why?
|
| Signal Transduction | 12 | 2020 | 3500 | 0.900 |
Why?
|
| Bone Morphogenetic Proteins | 7 | 2016 | 131 | 0.750 |
Why?
|
| Diabetes Mellitus, Type 1 | 3 | 2025 | 588 | 0.730 |
Why?
|
| Integrases | 2 | 2020 | 66 | 0.710 |
Why?
|
| Receptors, CXCR3 | 1 | 2021 | 13 | 0.700 |
Why?
|
| Organogenesis | 2 | 2020 | 50 | 0.670 |
Why?
|
| Lipoxygenases | 1 | 2020 | 3 | 0.660 |
Why?
|
| Tetracycline | 1 | 2020 | 13 | 0.650 |
Why?
|
| Inflammation Mediators | 1 | 2020 | 159 | 0.610 |
Why?
|
| Cell Differentiation | 4 | 2015 | 1616 | 0.600 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2020 | 163 | 0.590 |
Why?
|
| Animals | 38 | 2025 | 28148 | 0.550 |
Why?
|
| Animals, Genetically Modified | 6 | 2021 | 186 | 0.530 |
Why?
|
| Arachidonate 15-Lipoxygenase | 4 | 2025 | 18 | 0.510 |
Why?
|
| Reactive Oxygen Species | 2 | 2025 | 502 | 0.500 |
Why?
|
| Feedback, Physiological | 2 | 2016 | 66 | 0.490 |
Why?
|
| Stem Cells | 2 | 2015 | 386 | 0.480 |
Why?
|
| Cytokines | 1 | 2020 | 863 | 0.480 |
Why?
|
| Morphogenesis | 2 | 2016 | 206 | 0.470 |
Why?
|
| Polyamines | 1 | 2015 | 37 | 0.450 |
Why?
|
| Glucagon-Secreting Cells | 1 | 2015 | 27 | 0.450 |
Why?
|
| Glucagon | 1 | 2015 | 114 | 0.440 |
Why?
|
| Islets of Langerhans | 2 | 2015 | 557 | 0.440 |
Why?
|
| Macrophages | 4 | 2025 | 608 | 0.410 |
Why?
|
| Pancreatic Ducts | 1 | 2013 | 29 | 0.400 |
Why?
|
| Hepatocyte Growth Factor | 1 | 2013 | 86 | 0.390 |
Why?
|
| Holoprosencephaly | 3 | 2010 | 10 | 0.390 |
Why?
|
| Gene Expression Regulation, Developmental | 11 | 2020 | 665 | 0.380 |
Why?
|
| Cell Movement | 3 | 2025 | 809 | 0.380 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferases | 2 | 2010 | 61 | 0.380 |
Why?
|
| Inflammation | 4 | 2025 | 1049 | 0.360 |
Why?
|
| Lipoxygenase Inhibitors | 2 | 2025 | 34 | 0.360 |
Why?
|
| Proto-Oncogene Proteins c-met | 1 | 2013 | 199 | 0.350 |
Why?
|
| Oxidoreductases Acting on CH-NH Group Donors | 3 | 2025 | 23 | 0.350 |
Why?
|
| Insulin | 2 | 2015 | 1185 | 0.340 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 4 | 2010 | 190 | 0.320 |
Why?
|
| Glycoproteins | 4 | 2010 | 220 | 0.320 |
Why?
|
| Mice | 18 | 2025 | 12263 | 0.310 |
Why?
|
| Oxidative Stress | 4 | 2020 | 467 | 0.300 |
Why?
|
| Nitroreductases | 2 | 2008 | 4 | 0.290 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 2 | 2023 | 187 | 0.260 |
Why?
|
| Prosencephalon | 2 | 2010 | 68 | 0.260 |
Why?
|
| Endoplasmic Reticulum Stress | 3 | 2025 | 91 | 0.240 |
Why?
|
| Neural Crest | 1 | 2006 | 34 | 0.240 |
Why?
|
| Gene Knockdown Techniques | 2 | 2015 | 254 | 0.220 |
Why?
|
| Peptide Initiation Factors | 1 | 2025 | 30 | 0.220 |
Why?
|
| Disease Models, Animal | 3 | 2023 | 2494 | 0.220 |
Why?
|
| Blood Glucose | 3 | 2025 | 866 | 0.210 |
Why?
|
| Receptors, Leukotriene B4 | 1 | 2023 | 8 | 0.210 |
Why?
|
| Stress, Physiological | 1 | 2025 | 246 | 0.200 |
Why?
|
| Cell Proliferation | 5 | 2025 | 1740 | 0.190 |
Why?
|
| RNA-Binding Proteins | 1 | 2025 | 306 | 0.180 |
Why?
|
| Myocytes, Cardiac | 3 | 2016 | 313 | 0.180 |
Why?
|
| Up-Regulation | 2 | 2020 | 730 | 0.180 |
Why?
|
| Trans-Activators | 3 | 2015 | 439 | 0.180 |
Why?
|
| Transforming Growth Factor beta2 | 1 | 2021 | 16 | 0.170 |
Why?
|
| Smad2 Protein | 1 | 2021 | 24 | 0.170 |
Why?
|
| Body Patterning | 3 | 2010 | 214 | 0.170 |
Why?
|
| Primary Cell Culture | 1 | 2021 | 83 | 0.170 |
Why?
|
| Naphthalenes | 2 | 2019 | 40 | 0.170 |
Why?
|
| Isoxazoles | 2 | 2019 | 78 | 0.170 |
Why?
|
| Proteins | 2 | 2004 | 803 | 0.160 |
Why?
|
| Arachidonic Acid | 1 | 2020 | 62 | 0.160 |
Why?
|
| Carrier Proteins | 4 | 2010 | 663 | 0.160 |
Why?
|
| Models, Biological | 5 | 2017 | 1767 | 0.160 |
Why?
|
| Liver Neoplasms | 2 | 2023 | 776 | 0.160 |
Why?
|
| Interleukin-1beta | 1 | 2020 | 88 | 0.160 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2023 | 418 | 0.150 |
Why?
|
| Cell Survival | 4 | 2012 | 1004 | 0.150 |
Why?
|
| Interferon-gamma | 1 | 2020 | 460 | 0.140 |
Why?
|
| Obesity | 1 | 2025 | 1017 | 0.140 |
Why?
|
| Endoderm | 2 | 2015 | 25 | 0.140 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2019 | 216 | 0.130 |
Why?
|
| Hydroxyquinolines | 1 | 2017 | 4 | 0.130 |
Why?
|
| Immunity, Innate | 1 | 2021 | 463 | 0.130 |
Why?
|
| Cell Lineage | 2 | 2016 | 321 | 0.130 |
Why?
|
| Thiophenes | 1 | 2017 | 44 | 0.130 |
Why?
|
| Liver | 2 | 2023 | 1206 | 0.130 |
Why?
|
| Glucose | 1 | 2020 | 692 | 0.130 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2020 | 688 | 0.130 |
Why?
|
| MicroRNAs | 1 | 2021 | 580 | 0.120 |
Why?
|
| Blastomeres | 1 | 2015 | 7 | 0.120 |
Why?
|
| Receptor, Insulin | 1 | 2015 | 60 | 0.120 |
Why?
|
| Ornithine Decarboxylase | 1 | 2015 | 10 | 0.120 |
Why?
|
| Eflornithine | 1 | 2015 | 17 | 0.120 |
Why?
|
| Morpholinos | 1 | 2015 | 13 | 0.120 |
Why?
|
| Spermidine | 1 | 2015 | 13 | 0.120 |
Why?
|
| Cell Transdifferentiation | 1 | 2015 | 13 | 0.110 |
Why?
|
| DNA Methylation | 2 | 2010 | 697 | 0.110 |
Why?
|
| Embryo, Mammalian | 3 | 2010 | 217 | 0.110 |
Why?
|
| Mice, Knockout | 4 | 2019 | 2120 | 0.110 |
Why?
|
| Glucagon-Like Peptide 1 | 1 | 2015 | 59 | 0.110 |
Why?
|
| Phenotype | 3 | 2021 | 2544 | 0.110 |
Why?
|
| Hepatocytes | 2 | 2012 | 128 | 0.100 |
Why?
|
| Craniofacial Abnormalities | 2 | 2004 | 35 | 0.100 |
Why?
|
| Nodal Protein | 2 | 2010 | 5 | 0.100 |
Why?
|
| Cell Adhesion Molecules | 2 | 2004 | 174 | 0.100 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferase 1 | 2 | 2010 | 20 | 0.100 |
Why?
|
| STAT3 Transcription Factor | 1 | 2013 | 87 | 0.100 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2013 | 94 | 0.100 |
Why?
|
| Adenosine-5'-(N-ethylcarboxamide) | 1 | 2012 | 1 | 0.090 |
Why?
|
| Purinergic P1 Receptor Agonists | 1 | 2012 | 1 | 0.090 |
Why?
|
| Oculocerebrorenal Syndrome | 1 | 2012 | 1 | 0.090 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2013 | 282 | 0.090 |
Why?
|
| Cilia | 1 | 2012 | 29 | 0.090 |
Why?
|
| Apoptosis | 4 | 2010 | 1721 | 0.090 |
Why?
|
| Ketone Bodies | 1 | 2012 | 15 | 0.090 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2012 | 43 | 0.090 |
Why?
|
| Homeodomain Proteins | 1 | 2015 | 556 | 0.090 |
Why?
|
| Heart Ventricles | 1 | 2016 | 650 | 0.090 |
Why?
|
| Mutation, Missense | 1 | 2013 | 297 | 0.090 |
Why?
|
| Mice, Inbred NOD | 2 | 2025 | 215 | 0.090 |
Why?
|
| Monocarboxylic Acid Transporters | 1 | 2012 | 86 | 0.090 |
Why?
|
| Fasting | 1 | 2012 | 163 | 0.090 |
Why?
|
| Pancreas, Exocrine | 1 | 2011 | 18 | 0.080 |
Why?
|
| Gastrula | 1 | 2010 | 27 | 0.080 |
Why?
|
| GATA Transcription Factors | 1 | 2010 | 4 | 0.080 |
Why?
|
| Mice, Inbred ICR | 2 | 2008 | 75 | 0.080 |
Why?
|
| Lens, Crystalline | 1 | 2010 | 67 | 0.080 |
Why?
|
| Green Fluorescent Proteins | 2 | 2008 | 308 | 0.080 |
Why?
|
| Diabetes Mellitus | 1 | 2016 | 766 | 0.080 |
Why?
|
| Heart | 2 | 2010 | 522 | 0.080 |
Why?
|
| Interphase | 1 | 2009 | 36 | 0.080 |
Why?
|
| Endocrine Cells | 1 | 2009 | 3 | 0.080 |
Why?
|
| Embryonic Development | 1 | 2010 | 83 | 0.070 |
Why?
|
| Adenosine | 1 | 2012 | 275 | 0.070 |
Why?
|
| Genes, Reporter | 1 | 2009 | 275 | 0.070 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2009 | 307 | 0.070 |
Why?
|
| Humans | 11 | 2025 | 93501 | 0.070 |
Why?
|
| Metronidazole | 1 | 2008 | 26 | 0.070 |
Why?
|
| Female | 6 | 2025 | 48696 | 0.070 |
Why?
|
| Mesoderm | 1 | 2008 | 122 | 0.070 |
Why?
|
| Transforming Growth Factor beta | 2 | 2008 | 346 | 0.070 |
Why?
|
| Prodrugs | 1 | 2008 | 51 | 0.070 |
Why?
|
| Genes, Transgenic, Suicide | 1 | 2007 | 4 | 0.070 |
Why?
|
| Adipose Tissue | 2 | 2021 | 270 | 0.060 |
Why?
|
| Cell Death | 1 | 2008 | 253 | 0.060 |
Why?
|
| Facial Bones | 1 | 2006 | 37 | 0.060 |
Why?
|
| Genetic Engineering | 1 | 2007 | 100 | 0.060 |
Why?
|
| Oxidation-Reduction | 1 | 2008 | 410 | 0.060 |
Why?
|
| Microscopy, Fluorescence | 1 | 2008 | 435 | 0.060 |
Why?
|
| Bone Morphogenetic Protein 2 | 1 | 2006 | 62 | 0.060 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2008 | 555 | 0.060 |
Why?
|
| Amino Acid Sequence | 1 | 2009 | 2012 | 0.060 |
Why?
|
| Base Sequence | 1 | 2009 | 2220 | 0.060 |
Why?
|
| eIF-2 Kinase | 1 | 2025 | 50 | 0.060 |
Why?
|
| Embryo, Nonmammalian | 3 | 2012 | 201 | 0.060 |
Why?
|
| Molecular Sequence Data | 1 | 2009 | 2910 | 0.060 |
Why?
|
| Skull | 1 | 2006 | 270 | 0.050 |
Why?
|
| Upper Gastrointestinal Tract | 1 | 2004 | 9 | 0.050 |
Why?
|
| Diet, High-Fat | 1 | 2025 | 134 | 0.050 |
Why?
|
| Leukotriene B4 | 1 | 2023 | 16 | 0.050 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2004 | 78 | 0.050 |
Why?
|
| Protein Isoforms | 1 | 2025 | 295 | 0.050 |
Why?
|
| Lysine | 1 | 2025 | 182 | 0.050 |
Why?
|
| Transcription Factors | 1 | 2011 | 1691 | 0.050 |
Why?
|
| Organizers, Embryonic | 1 | 2002 | 6 | 0.050 |
Why?
|
| Culture Techniques | 1 | 2002 | 81 | 0.050 |
Why?
|
| Fibroblast Growth Factor 8 | 1 | 2002 | 28 | 0.050 |
Why?
|
| Male | 2 | 2025 | 44552 | 0.050 |
Why?
|
| Fibroblast Growth Factors | 1 | 2002 | 86 | 0.050 |
Why?
|
| Neovascularization, Pathologic | 1 | 2004 | 353 | 0.050 |
Why?
|
| Larva | 2 | 2012 | 133 | 0.040 |
Why?
|
| Liver Cirrhosis | 1 | 2023 | 273 | 0.040 |
Why?
|
| Cell Division | 1 | 2002 | 693 | 0.040 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2004 | 666 | 0.040 |
Why?
|
| Protein Binding | 2 | 2017 | 1534 | 0.040 |
Why?
|
| Colonic Neoplasms | 1 | 2004 | 579 | 0.040 |
Why?
|
| Streptozocin | 1 | 2019 | 56 | 0.040 |
Why?
|
| Pregnancy | 1 | 2006 | 3147 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 1 | 2025 | 3434 | 0.030 |
Why?
|
| Gene Deletion | 1 | 2019 | 352 | 0.030 |
Why?
|
| Molecular Structure | 1 | 2017 | 307 | 0.030 |
Why?
|
| Jagged-2 Protein | 1 | 2016 | 6 | 0.030 |
Why?
|
| Immunohistochemistry | 2 | 2012 | 1799 | 0.030 |
Why?
|
| Calcium-Binding Proteins | 1 | 2016 | 118 | 0.030 |
Why?
|
| Receptors, Notch | 1 | 2016 | 136 | 0.030 |
Why?
|
| Organ Size | 1 | 2016 | 362 | 0.030 |
Why?
|
| Autophagy | 1 | 2017 | 172 | 0.030 |
Why?
|
| RNA, Messenger | 1 | 2021 | 2026 | 0.030 |
Why?
|
| Rats | 1 | 2021 | 4072 | 0.030 |
Why?
|
| Insulin Resistance | 1 | 2017 | 378 | 0.030 |
Why?
|
| Mutation | 3 | 2012 | 4272 | 0.030 |
Why?
|
| Integrin alphaVbeta3 | 2 | 2004 | 16 | 0.030 |
Why?
|
| Receptor, ErbB-2 | 1 | 2016 | 280 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2017 | 1723 | 0.030 |
Why?
|
| Brain | 1 | 2004 | 2391 | 0.020 |
Why?
|
| Software | 1 | 2017 | 670 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2017 | 1118 | 0.020 |
Why?
|
| Gene Expression Profiling | 2 | 2012 | 1518 | 0.020 |
Why?
|
| Receptor, Adenosine A2A | 1 | 2012 | 16 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2017 | 2848 | 0.020 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2012 | 109 | 0.020 |
Why?
|
| Xenopus | 1 | 2012 | 119 | 0.020 |
Why?
|
| Kidney Tubules | 1 | 2012 | 91 | 0.020 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2012 | 201 | 0.020 |
Why?
|
| Endothelial Cells | 2 | 2004 | 476 | 0.020 |
Why?
|
| Fatty Liver | 1 | 2012 | 106 | 0.020 |
Why?
|
| Primitive Streak | 1 | 2010 | 2 | 0.020 |
Why?
|
| Transfection | 1 | 2012 | 880 | 0.020 |
Why?
|
| Gene Expression Regulation, Plant | 1 | 2010 | 95 | 0.020 |
Why?
|
| Breast Neoplasms | 1 | 2004 | 3110 | 0.020 |
Why?
|
| Electric Conductivity | 1 | 2010 | 142 | 0.020 |
Why?
|
| Extracellular Space | 1 | 2010 | 88 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2010 | 224 | 0.020 |
Why?
|
| Epithelium | 1 | 2010 | 316 | 0.020 |
Why?
|
| Molecular Probe Techniques | 1 | 2009 | 10 | 0.020 |
Why?
|
| Fibroblasts | 1 | 2012 | 756 | 0.020 |
Why?
|
| Protein Multimerization | 1 | 2010 | 191 | 0.020 |
Why?
|
| Retina | 1 | 2010 | 215 | 0.020 |
Why?
|
| Bone Morphogenetic Protein 4 | 1 | 2008 | 16 | 0.020 |
Why?
|
| Animals, Outbred Strains | 1 | 2008 | 16 | 0.020 |
Why?
|
| Organ Culture Techniques | 1 | 2008 | 121 | 0.020 |
Why?
|
| Genotype | 1 | 2012 | 1866 | 0.020 |
Why?
|
| Alleles | 1 | 2010 | 1139 | 0.020 |
Why?
|
| Organ Specificity | 1 | 2007 | 279 | 0.020 |
Why?
|
| Epigenesis, Genetic | 1 | 2010 | 555 | 0.020 |
Why?
|
| Focal Adhesion Protein-Tyrosine Kinases | 1 | 2004 | 31 | 0.010 |
Why?
|
| Focal Adhesion Kinase 1 | 1 | 2004 | 30 | 0.010 |
Why?
|
| Mammary Glands, Human | 1 | 2004 | 26 | 0.010 |
Why?
|
| Histological Techniques | 1 | 2004 | 33 | 0.010 |
Why?
|
| Blotting, Southern | 1 | 2004 | 110 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 2004 | 244 | 0.010 |
Why?
|
| Crosses, Genetic | 1 | 2004 | 165 | 0.010 |
Why?
|
| Myocardium | 1 | 2007 | 570 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2007 | 962 | 0.010 |
Why?
|
| Mice, SCID | 1 | 2004 | 271 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 2004 | 309 | 0.010 |
Why?
|
| Neoplasm Transplantation | 1 | 2004 | 399 | 0.010 |
Why?
|
| Biomarkers | 1 | 2010 | 1910 | 0.010 |
Why?
|
| Hedgehog Proteins | 1 | 2004 | 105 | 0.010 |
Why?
|
| Cell Hypoxia | 1 | 2004 | 187 | 0.010 |
Why?
|
| DNA Primers | 1 | 2004 | 531 | 0.010 |
Why?
|
| Transplantation, Heterologous | 1 | 2004 | 371 | 0.010 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2004 | 302 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2004 | 1028 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2004 | 366 | 0.010 |
Why?
|
| Mice, Nude | 1 | 2004 | 824 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2004 | 691 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2010 | 1985 | 0.010 |
Why?
|
| Colon | 1 | 2004 | 540 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2004 | 1338 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2004 | 2755 | 0.010 |
Why?
|